Pure BiologicsS.A.Active

Research and experimental development on biotechnology

KRS: 0000712811 NIP: 8943003192 REGON: 02130577200000

Overview

Registry date
2018-01-10
Share capital
$330,759.48
Activity description

PURE Biologics develops new immuno-oncology therapies based on antibody technologies. Its portfolio includes PB004, PB003G and PBA-0405, with updates on Phase 0 studies and FDA clearance to advance these projects. PURE Biologics says it is the first company in Poland focused on developing entirely new biological drugs, not generic or biosimilar medicines.

Registered address
Ul. Szczytnicka 11, 50-382 Wrocław, Poland
Website
purebiologics.comWebsite active
Email
Email address current
Electronic delivery address
AE:PL-43264-33950-CUGUE-31

Industry

NameCode
Research and experimental development on biotechnology
72.11.Z
Manufacture of other organic basic chemicals
20.14.Z
Manufacture of other chemical products n.e.c.
20.59.Z
Manufacture of basic pharmaceutical products
21.10.Z
Manufacture of pharmaceutical preparations
21.20.Z

Bank accounts

Registered as a VAT taxpayer on 2010-08-01.Active
  • mBank
    23 1140 1140 0000 2764 7300 1016
  • mBank
    13 1140 1140 0000 2764 7300 1002
  • mBank
    34 1140 1140 0000 2764 7300 1012

Authorized Representatives

Ownership

Subsidiaries

NameSharesShare value% in company
BIO Animalisp. z o.o.304,051.86 USD15%

FAQ

Last updated: 2026-07-15